review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/0163-7258(90)90084-F |
P698 | PubMed publication ID | 2203068 |
P2093 | author name string | Davis M | |
P433 | issue | 2 | |
P921 | main subject | anxiety | Q154430 |
P304 | page(s) | 147-165 | |
P577 | publication date | 1990-01-01 | |
P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
P1476 | title | Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect | |
P478 | volume | 47 |
Q40457638 | 5-Hydroxytryptamine pathways in anxiety and its treatment |
Q60622978 | Acoustic startle in maltreated children |
Q30412308 | Age- and sex-dependent effects of footshock stress on subsequent alcohol drinking and acoustic startle behavior in mice selectively bred for high-alcohol preference |
Q30500018 | Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex |
Q35407089 | Antagonizing corticotropin-releasing factor in the central nucleus of the amygdala attenuates fear-induced reductions in sleep but not freezing |
Q51101232 | Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. |
Q78052278 | Automated analysis of foot-shock sensitivity and concurrent freezing behavior in mice |
Q90222366 | Autonomic responses to fear conditioning among women with PTSD and dissociation |
Q36728468 | Basolateral amygdala and the regulation of fear-conditioned changes in sleep: role of corticotropin-releasing factor |
Q36980075 | Behavioral measures of tinnitus in laboratory animals |
Q44936841 | Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds |
Q30480573 | CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues |
Q57513867 | Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders |
Q93216241 | Chronic inhibition of GABA synthesis in the infralimbic cortex facilitates conditioned safety memory and reduces contextual fear |
Q28508341 | Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice |
Q30464836 | Context, emotion, and the strategic pursuit of goals: interactions among multiple brain systems controlling motivated behavior. |
Q48824455 | Differences in fear motivated behaviors among inbred mouse strains |
Q52051168 | Differential acquisition of specific components of a classically conditioned arterial blood pressure response in rat. |
Q40174485 | Differential acquisition, extinction, and reinstatement of conditioned suppression in mice. |
Q37347970 | Differential effects of lorazepam on sleep and activity in C57BL/6J and BALB/cJ strain mice |
Q27321760 | Effects of a Flavonoid-Rich Fraction on the Acquisition and Extinction of Fear Memory: Pharmacological and Molecular Approaches |
Q34997419 | Effects of stressor predictability and controllability on sleep, temperature, and fear behavior in mice |
Q30472672 | Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference |
Q30377507 | Estrogen and extinction of fear memories: implications for posttraumatic stress disorder treatment. |
Q36084337 | False context fear memory in rats |
Q44377038 | Further evidence of an inverse genetic relationship between innate differences in alcohol preference and alcohol withdrawal magnitude in multiple selectively bred rat lines |
Q37248304 | GABAergic antagonism of the central nucleus of the amygdala attenuates reductions in rapid eye movement sleep after inescapable footshock stress |
Q47367059 | Genetic correlation between alcohol preference and conditioned fear: Exploring a functional relationship |
Q50903339 | Genetic correlation between innate alcohol preference and fear-potentiated startle in selected mouse lines. |
Q30478587 | Genetics of anxiety and trauma-related disorders |
Q30475836 | Haploinsufficiency in peptidylglycine alpha-amidating monooxygenase leads to altered synaptic transmission in the amygdala and impaired emotional responses |
Q30476607 | Impaired fear inhibition is a biomarker of PTSD but not depression |
Q34062489 | Incubation of conditioned fear in the conditioned suppression model in rats: role of food-restriction conditions, length of conditioned stimulus, and generality to conditioned freezing. |
Q30368948 | Individual Differences in Animal Stress Models: Considering Resilience, Vulnerability, and the Amygdala in Mediating the Effects of Stress and Conditioned Fear on Sleep |
Q34117794 | Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety |
Q36918176 | Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory |
Q44071534 | Lead and conditioned fear to contextual and discrete cues |
Q28484969 | Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice |
Q33862518 | Measurement of anxiety in transgenic mice. |
Q45267857 | Mild interoceptive stressors affect learning and reactivity to contextual cues: toward understanding the development of unexplained illnesses. |
Q30474911 | Moderate recurrent hypoglycemia during early development leads to persistent changes in affective behavior in the rat. |
Q48560852 | Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s |
Q34510367 | Molecular pathways of anxiety revealed by knockout mice |
Q36459652 | Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness |
Q50781836 | Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. |
Q35132683 | Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder |
Q51057187 | Neural plasticity and stress induced changes in defense in the rat. |
Q28511234 | Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis |
Q44086542 | Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala |
Q30223910 | Not all stressors are equal: behavioral and endocrine evidence for development of contextual fear conditioning after a single session of footshocks but not of immobilization |
Q30433061 | Origin and function of short-latency inputs to the neural substrates underlying the acoustic startle reflex |
Q34539708 | Posttraumatic stress disorder in women: assessment and treatment in primary care |
Q39015847 | Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociceptin receptors |
Q34415600 | Retigabine: chemical synthesis to clinical application. |
Q51107407 | Ritanserin facilitates anxiety in a simulated public-speaking paradigm. |
Q41544963 | Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. |
Q45922543 | Selective effects of benzodiazepines on the acquisition of conditioned taste aversion compared to attenuation of neophobia in C57BL/6 mice. |
Q26795477 | The Physiology of Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning |
Q30462832 | The age of anxiety: role of animal models of anxiolytic action in drug discovery |
Q36247092 | The ascent of mouse: advances in modelling human depression and anxiety |
Q39211091 | The basolateral amygdala can mediate the effects of fear memory on sleep independently of fear behavior and the peripheral stress response |
Q30413016 | The basolateral amygdala determines the effects of fear memory on sleep in an animal model of PTSD |
Q35167484 | The defense system of fear: behavior and neurocircuitry |
Q30446324 | Translational neuroscience measures of fear conditioning across development: applications to high-risk children and adolescents |
Q34212336 | Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists. |
Search more.